To amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program.
Sponsors
Legislative Progress
ReportedReported by Mr. Sanders, without amendment
Reported by Mr. Sanders, without amendment
Reported by Mr. Sanders, without amendment
Reported by Mr. Sanders, without amendment
Reported by Mr. Sanders, without amendment
Reported by Mr. Sanders, without amendment
Reported by Mr. Sanders, without amendment
Reported by Mr. Sanders, without amendment
Reported by Mr. Sanders, without amendment
Reported by Mr. Sanders, without amendment
Summary
What This Bill Does
Reauthorizes sickle cell disease prevention and treatment programs with expanded focus on preventing and treating complications. Increases funding authorization.
Who Benefits and How
Sickle cell patients gain improved treatment programs. Research on complications expanded. Prevention efforts enhanced.
Who Bears the Burden and How
HHS administers reauthorized programs. Funding required for expanded scope.
Key Provisions
- Reauthorizes sickle cell treatment programs
- Adds focus on prevention of complications
- Expands authority to grants and cooperative agreements
Evidence Chain:
This summary is derived from the structured analysis below. See "Detailed Analysis" for per-title beneficiaries/burden bearers with clause-level evidence links.
Primary Purpose
Reauthorizes sickle cell disease prevention, treatment, and surveillance programs
Policy Domains
Legislative Strategy
"Continue and expand sickle cell disease programs"
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology